All data are preliminary and may change as more reports are received.

Synopsis: During week 14 (April 1-7, 2012), influenza activity was elevated in some areas of the United States, but declined nationally and in most regions.

• U.S. Virologic Surveillance: Of the 3,607 specimens tested by U.S. World Health

• Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and reported to CDC/Influenza Division, 756 (21.0%) were positive for influenza.

• Novel Influenza A Virus: One human infection with a novel influenza A virus was identified.

• Pneumonia and Influenza (P&I) Mortality Surveillance: The proportion of deaths

• attributed to P&I was below the epidemic threshold.

• Influenza-associated Pediatric Mortality: No influenza-associated pediatric deaths were reported.

• Outpatient Illness Surveillance: The proportion of outpatient visits for influenza-like illness (ILI) was 1.5%, which is below the national baseline of 2.4%. Region 10 reported ILI above its region-specific baseline level. One state experienced moderate ILI activity, 1 state experienced low ILI activity; New York City and 48 states experienced minimal ILI activity, and the District of Columbia had insufficient data to calculate ILI activity.

• Geographic Spread of Influenza: Ten states reported widespread geographic activity; 9 states reported regional influenza activity; 20 states reported local activity; the District of Columbia, Puerto Rico, and 11 states reported sporadic activity, and Guam and the U.S. Virgin Islands reported no influenza activity.

External_F1214.pdf

Publication date from document properties.